secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aardvark Therapeutics, Inc. (AARD)
CIK:        0001774857
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0001193125-25-027245
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aardvark Therapeutics completes IPO; issues 5.888M shares at $16.00, raises $94.2M gross
--------------------------------------------------------------------------------

- IPO of 5,888,000 shares at $16.00 per share completed on Feb 14, 2025.
- Gross proceeds $94.2M before underwriting discounts and commissions.
- Amended certificate authorizes 490M common shares and 10M preferred shares.
- Amended bylaws establish classified board, stockholder proposal procedures, and exclusive forum provision.
- Common stock trades on Nasdaq under ticker AARD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/0001193125-25-027245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/d890894d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-027245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer